# ANDA212891
> **ANDA212891** · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMS LTD · Approved 2024-07-23
## Drug
- **FDA Application Number:** ANDA212891
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** TORRENT PHARMS LTD
- **First approval:** 2024-07-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212891)
---
*MORVS · CC0 1.0*